✦ LIBER ✦

Antibody nature of an AHG (Factor VIII)inhibitor

✍ Scribed by Jeanne M. Lusher; Joseph Shuster; Ruth K. Evans; M.D. Poulik

Book ID: 118535489
Publisher: Elsevier Science
Year: 1968
Tongue: English
Weight: 494 KB
Volume: 72
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(68)80203-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody Nature of the Inhibitor to Anti

Antibody Nature of the Inhibitor to Antihaemophilic Globulin (Factor VIII)

✍ BIDWELL, E.; DENSON, K. W. E.; DIKE, G. W. R.; AUGUSTIN, R.; LLOYD, G. M. 📂 Article 📅 1966 🏛 Nature Publishing Group 🌐 English ⚖ 304 KB

Transient factor VIII inhibitor and trea

Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIII

✍ Montoro, JoséB.; Rodríguez, Santiago; Altisent, Carme; Tusell, JoanM. 📂 Article 📅 1991 🏛 The Lancet 🌐 English ⚖ 169 KB

Immunochemistry of factor VIII:C inhibit

Immunochemistry of factor VIII:C inhibitor antibodies

✍ Carol A. Fulcher 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 376 KB

USE OF ANIMAL AHG CONCENTRATES (FACTOR V

USE OF ANIMAL AHG CONCENTRATES (FACTOR VIII) IN THE TREATMENT OF LIFE-THREATENING HEMORRHAGE IN PATIENTS WITH FACTOR VIII ANTIBODIES

✍ R. Rubin; J. Niemetz; S. Estren 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

Inhibitors to monoclonal antibody purifi

Inhibitors to monoclonal antibody purified factor VIII

✍ Bell, BeverlyA.; Kurczynski, ElizabethM.; Bergman, Garrett 📂 Article 📅 1990 🏛 The Lancet 🌐 English ⚖ 177 KB

Transient inhibitor to monoclonal antibo

Transient inhibitor to monoclonal antibody-purified factor VIII concentrate

✍ May L. Votaw; Sheri Miller 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Letters and Correspondence ## 297 percentage of ring sideroblasts in our patients ranged between 15% and 85%. According to our recently published criteria [4], two patients had pure sideroblastic anemia (PSA), which is confined to dyserythropoiesis, and